摘要
Breast cancer is the leading cause of cancer-related deaths in women and remains a formidable therapeutic challenge. Mitochondria participate in a myriad of essential cellular processes, such as metabolism, and are becoming an ideal target for cancer therapy. Artemisinin and its derivatives have demonstrated multiple activities in the context of various cancers. Mitochondrial autophagy(mitophagy) is one of the important anti-tumor mechanisms of artemisinin drugs. However, the lack of specific tumor targeting ability limits the anti-tumor efficacy of artemisinin drugs. In this study, a GSH-sensitive artesunate smart conjugate (TPP-SS-ATS) was synthesized and liposomes (TPP-SS-ATS-LS) that target tumor cells and mitochondria were further prepared. The advantages of TPP-SS-ATS-LS targeting to the breast tumor were verified by in vivo and in vitro evaluations. In our study, the cytotoxicity was obviously enhanced in vitro and tumor growth inhibition rate was increased from 37.7% to 56.4% at equivalent artesunate dosage in breast cancer orthotopic implanted mice. Meanwhile, mitochondrial dysfunction, suppression of ATP production and respiratory capacity were detected in breast cancer cells. We further discovered that TPP-SS-ATS-LS inhibited tumor cells proliferation through mitophagy by regulating PHB2 and PINK1 These results provide new research strategies for the development of new artemisinin-based anti-tumor drugs.
学科与关键词
- Mitochondrial-Targeted Triphenylphosphonium-Hydroxycamptothecin Conjugate and Its Nano-Formulations for Breast Cancer Therapy: In Vitro and In Vivo InvestigationZhang, Kunfeng; Fu, Jingxin; Liu, Xiaorui; Guo, Yifei; Han, Meihua; Liu, Meifeng*; Wang, Xiangtao*Pharmaceutics, 2023, 15(2): 388.被引 2
- Ferroptosis: A New Research Direction of Artemisinin and Its Derivatives in Anti-Cancer TreatmentWang, Youke; Yuan, Xiang; Ren, Min*; Wang, Zhiyu*AMERICAN JOURNAL OF CHINESE MEDICINE, 2024.
- Discovery of PlatinumIV-Artesunate Multiaction Prodrugs as Potent Antitumor and Antimalarial AgentsLiu, Wei; Yu, Chuyi; Wang, Miaomiao; He, Youyou; Guo, Zhongjie; He, Jin; Jiang, Ru; Xu, Qin; Liang, Jianming*; Wang, Shengzheng*Journal of Medicinal Chemistry, 2023.被引 2
